Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibition (ICI) improves survival outcomes for patients with several types of cancer including metastatic melanoma (MM), but serious immune-related adverse events requiring intervention with immunosuppressive medications occur in a subset of patients. Skin toxicity (ST...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Nicholas, Donnelly, Douglas, Qian, Yingzhi, Moran, Una, Johannet, Paul, Zhong, Judy, Osman, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659132/
https://www.ncbi.nlm.nih.gov/pubmed/33176813
http://dx.doi.org/10.1186/s12967-020-02612-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659132/
https://www.ncbi.nlm.nih.gov/pubmed/33176813
http://dx.doi.org/10.1186/s12967-020-02612-5

Ejemplares similares